Skip to content

SharpLink

US · SBET #2752 by market cap Listed 1970
8.95 -0.55 -5.79%
Live - 5344 symbols - heartbeat 445s ago · 2026-10-08 07:40
Pre-market 8.66 -3.24%
After-hours 8.98 +0.34%
Overnight 8.96 +0.11%
Market cap
1.94B
P/B
1.38
EPS
-7.37
Reader sentiment Are you bullish or bearish on SBET?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio 1.46 In line with history 54th percentile
5-year average 45.48 · #36 of 93 in Capital Markets
P/E ratio -2.12 Cheap vs history 11th percentile
5-year average -0.85 · forward -374.56
P/S ratio 41.11 Expensive vs history 81st percentile
5-year average 86.26 · forward 29.51 · #86 of 94 in Capital Markets

Vs. peers Capital Markets

Company Market cap P/E (TTM) P/B Div yield
SharpLink (SBET) 1.94B -1.99 1.38 0.00%
Morgan Stanley (MS) 297.95B 15.32 2.80 2.11%
Goldman Sachs (GS) 258.33B 13.70 2.35 1.92%
Charles Schwab (SCHW) 165.29B 17.41 3.76 1.23%
Robinhood (HOOD) 98.46B 48.46 10.39 0.00%
Interactive Brokers (IBKR) 39.75B 34.82 6.73 0.37%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value9.11 Economic moatNone UncertaintyVery High

Trading 1.8% below Morningstar's fair value estimate.

Fair value

Sharplink Inc earns a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 5% premium over our quantitative fair value estimate of $9.11 per share; however, this estimate should be taken with a pinch of salt due to its very high uncertainty rating.

The firm's lack of profitability weakens our fair value estimate. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. Reflecting the firm's profitability is its sales yield of 2.7%, which ranks in the bottom 10% compared with global peers. This company's inability to generate significant sales growth without meaningful capital investment is a challenge, which contributes to our view that shares are overvalued.

The firm's valuation metrics are an additional cause for concern. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to EBITDA ratio of 128.0, a core component of valuation, sits in the top 10% compared with peers globally. This suggests that the value of its enterprise value, or the value of its shares and debt, is a high multiple of the generated EBITDA. This characteristic further promotes our unfavorable price/fair value ratio.

Economic moat

This company lacks a competitive advantage, receiving a quantitative economic moat rating of none. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-08 07:40:19 · For reference only, not investment advice and not tailored to your situation.